Moreover, low ADARB2 expression is associated with the enrichment of oncogenic pathways such as Wnt/β-catenin, Notch, Hedgehog, and TGF-β1 signaling, which may contribute to aggressive tumor behavior. The gene discussed is ADARB2; the disease is neoplasm.